Hi I want someone can help to solve these answers I will upload all the chapters
- Identify the neuromuscular blocking agent that is associated with malignant hyperthermia.
- Identify the negative outcome that can result from relying only on clinical features that do not include sputum culture to diagnose VAP.
- List causes and risk factors for VAP.
- Describe the pathogenesis of VAP.
- List clinical findings seen with VAP.
- Identify the most common organism type seen in VAP.
- Identify the incidence of VAP for all intubated patients.
- Identify the common bacteria seen in the upper airway of healthy people.
- Identify the clinical lab study that contributes the most toward the effective treatment of VAP.
- List commonly used benzodiazepines in the ICU.
- Identify time required for the onset of symptoms for a respiratory infection to be considered VAP.
- Identify the most useful feature of dexmedetomidine (Etomidate) in the ICU.
- List items typically included in a ventilator bundle.
- Identify the mortality rate for VAP.
- List items included in the updated definition of VAP.
- List interventions that may reduce the risk of VAP.
- Differentiate features of mild, moderate and deep sedation.
- Identify the medication type that may be useful in a case where patient-ventilator asynchrony cannot be corrected.
